[Acute myocarditis in a young adult two days after Pfizer vaccination]. / Miocardite acuta in giovane adulto due giorni dopo vaccino Pfizer.
G Ital Cardiol (Rome)
; 22(11): 891-893, 2021 Nov.
Article
in Italian
| MEDLINE | ID: covidwho-1496711
ABSTRACT
We report the case of a 20-year-old healthy male who developed acute myopericarditis 2 days after receiving the second dose of the mRNA Pfizer-BioNTech COVID-19 vaccine. The course of the disease was mild and the patient was discharged after a few days of hospitalization.Recently, several case reports involving myopericarditis in patients who received an mRNA vaccine against SARS-CoV-2 have been published and the U.S. Centers for Disease Control and Prevention and the European Medicines Agency pharmacovigilance risk assessment committee are currently investigating an overall increased number of cases. They are also assessing whether there is a higher incidence than expected in vaccinated young adults and teenagers, especially males. Although a clear causal link has not been proven at this time, physicians should be aware of such potential adverse event, taking into account the increasing number of young people that will receive mRNA vaccination over the next few months.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
COVID-19
/
Myocarditis
Type of study:
Case report
/
Diagnostic study
/
Observational study
/
Prognostic study
Topics:
Vaccines
Limits:
Adolescent
/
Adult
/
Humans
/
Male
/
Young adult
Language:
Italian
Journal:
G Ital Cardiol (Rome)
Journal subject:
Cardiology
Year:
2021
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS